Physician profile
Lamar Davis
NPI 1003006206
$4,387.40
in general payments reported to CMS, 2019-2025
11 companies · $1,840 in 2025
The $1,840 reported for 2025 was more than what 78% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $1,966 · 2022: $180 · 2023: $34.95 · 2025: $1,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,693 · Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,693.00 |
| Food and Beverage | $182.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $3,934.21 | 2019-2025 | |
| Ucb, INC. | $90.54 | 2019 | |
| Eisai INC. | $79.43 | 2019 | |
| Greenwich Biosciences, INC. | $60.62 | 2019-2020 | |
| Ptc Therapeutics, INC. | $58.75 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $40.86 | 2019 | |
| Sarepta Therapeutics, INC. | $34.95 | 2023 | |
| Saol Therapeutics INC. | $24.91 | 2020 | |
| Ironshore Pharmaceuticals INC. | $22.05 | 2019 | |
| Jazz Pharmaceuticals INC. | $21.69 | 2022 | |
| Livanova USA, INC. | $19.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lamar Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.